Immediate release formulation of a triple combination of active pharmaceutical ingredients useful in the treatment of polycystic ovary syndrome
WO2020128115A1
Rehabilitation device for the lower extremities
EP3660169A1
Markers for predicting weight loss treatment response in children
EP3378458A1
Containment and sensory stimulation system for premature babies
ES2690160A1
Classification method in molecular subgroups of patients with medulloblastoma
EP3400935A1
Betaine for the prevention of obesity
CN106794275A
For the system of release bioactive agent immediately
US2018207111A1
Immunotherapy for casr-expressing cancer (e.g. neuroblastoma)
WO2014076270A1
Soluble collagen vi for use in the treatment of hyperglycemia linked diseases and glucose transport disorders. pharmaceutical composition, method and use of a cell extracellular liquid medium for increasing glucose uptake
ES2498800A1
DEVICE AND RESPIRATORY EXERCISE PROCEDURE
ES2394277A1
DEVICE FOR COLLECTION, STORAGE AND TRANSPORTATION OF BIOLOGICAL SAMPLES
ES2388165A1
Prognosis method of neuroblastic tumors
ES2384069A1
Cinacalcet and neuroblastic tumors
ES2379236A1
METHOD OF PREDICTION OF FORECAST AND / OR PHARMACOLOGICAL RESPONSE IN NEUROBLASTOMA.
ES2371840A1
METHOD FOR THE FORECAST OF TUMORS OF THE DEVELOPMENT AND USE OF INHIBITORS OF GENE METHODATION FOR THE TREATMENT OF THE SAME.
ES2307454A1
TUMOR COLLECTOR FOR THE COLLECTION OF A TUMOR IN A SURGICAL INTERVENTION.
